145 related articles for article (PubMed ID: 28276897)
1. Computational modeling of radiobiological effects in bone metastases for different radionuclides.
Liberal FDCG; Tavares AAS; Tavares JMRS
Int J Radiat Biol; 2017 Jun; 93(6):627-636. PubMed ID: 28276897
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods.
Guerra Liberal FD; Tavares AA; Tavares JM
Med Phys; 2014 Nov; 41(11):114101. PubMed ID: 25370676
[TBL] [Abstract][Full Text] [Related]
3. Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153.
Guerra Liberal FDC; Tavares AAS; Tavares JMRS
Appl Radiat Isot; 2016 Apr; 110():87-99. PubMed ID: 26773820
[TBL] [Abstract][Full Text] [Related]
4. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on β-Emitting and α-Emitting Radionuclides.
Sadremomtaz A; Masoumi M
J Med Imaging Radiat Sci; 2019 Jun; 50(2):272-279. PubMed ID: 31176435
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on the potential use of
Zakaly HMH; Mostafa MYA; Deryabina D; Zhukovsky M
Int J Radiat Biol; 2020 Jun; 96(6):779-789. PubMed ID: 32043915
[No Abstract] [Full Text] [Related]
6. Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays.
Elgqvist J; Timmermand OV; Larsson E; Strand SE
Anticancer Res; 2016 Jan; 36(1):103-9. PubMed ID: 26722033
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo simulation of age-dependent radiation dose from alpha- and beta-emitting radionuclides to critical trabecular bone and bone marrow targets.
Dant JT; Richardson RB; Nie LH
Phys Med Biol; 2013 May; 58(10):3301-19. PubMed ID: 23615276
[TBL] [Abstract][Full Text] [Related]
8. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.
Handkiewicz-Junak D; Poeppel TD; Bodei L; Aktolun C; Ezziddin S; Giammarile F; Delgado-Bolton RC; Gabriel M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):846-859. PubMed ID: 29453701
[TBL] [Abstract][Full Text] [Related]
9. (223)Ra and other bone-targeting radiopharmaceuticals-the translation of radiation biology into clinical practice.
Turner PG; O'Sullivan JM
Br J Radiol; 2015 Jun; 88(1050):20140752. PubMed ID: 25811095
[TBL] [Abstract][Full Text] [Related]
10. Clinical dosimetry in the treatment of bone tumors: old and new agents.
Hindorf C; Flux GD; Ibisch C; Kraeber Bodéré F
Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):198-204. PubMed ID: 21386790
[TBL] [Abstract][Full Text] [Related]
11. Concerning the health effects of internally deposited radionuclides.
Raabe OG
Health Phys; 2010 Mar; 98(3):515-36. PubMed ID: 20147792
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the radiation absorbed dose produced by
Azorín-Vega E; Rojas-Calderón E; Ferro-Flores G; Aranda-Lara L; Jiménez-Mancilla N; Nava-Cabrera MA
Appl Radiat Isot; 2019 Apr; 146():66-71. PubMed ID: 30753987
[TBL] [Abstract][Full Text] [Related]
13. An assessment of bone-seeking radionuclides for palliation of metastatic bone pain in a vertebral model.
Sadremomtaz A; Masoumi M
Ann Nucl Med; 2019 Apr; 33(4):252-264. PubMed ID: 30659480
[TBL] [Abstract][Full Text] [Related]
14. Systemic Radiotherapy of Bone Metastases With Radionuclides.
Murray I; Du Y
Clin Oncol (R Coll Radiol); 2021 Feb; 33(2):98-105. PubMed ID: 33353771
[TBL] [Abstract][Full Text] [Related]
15. Model of metastatic growth valuable for radionuclide therapy.
Bernhardt P; Ahlman H; Forssell-Aronsson E
Med Phys; 2003 Dec; 30(12):3227-32. PubMed ID: 14713089
[TBL] [Abstract][Full Text] [Related]
16. Bone-targeting radiopharmaceuticals including radium-223.
Brady D; Parker CC; O'Sullivan JM
Cancer J; 2013; 19(1):71-8. PubMed ID: 23337760
[TBL] [Abstract][Full Text] [Related]
17. The management of painful bone metastases with an emphasis on radionuclide therapy.
Hillegonds DJ; Franklin S; Shelton DK; Vijayakumar S; Vijayakumar V
J Natl Med Assoc; 2007 Jul; 99(7):785-94. PubMed ID: 17668645
[TBL] [Abstract][Full Text] [Related]
18. A new look at radionuclides therapy in metastatic disease of bone (review and prospects).
Kim SI; Chen DC; Muggia FM
Anticancer Res; 1988; 8(4):681-4. PubMed ID: 2460020
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
20. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS
J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]